搜尋
Yahoo! 財經
你好!Guest
[ 用戶登入新用戶? ]

RBC Life Sciences Inc.
(RBCL.OB)

0.00 (0.00%)
0.230
最新價
2010年2月9日 HKT
買入: N/A昨日收市: N/A
賣出: N/A開市: N/A
今日波幅: N/A

基本資料

其他股份的基本資料:
RBC Life Sciences Inc.
2301 Crown Court
Irving, TX 75038
Phone: 972-893-4000
Fax: 972-893-4111
Web Site: http://www.rbclifesciences.com

 DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Related Products
Employees (last reported count):79

 REUTERS ABRIDGED BUSINESS SUMMARY 
RBC Life Sciences, Inc., together with its subsidiaries, markets and distributes nutritional supplements and personal care products primarily in the United States, the former Soviet Union, and Canada. It operates in two segments, Nutritional Products and Medical Products. The Nutritional Products segment provides a line of approximately 75 nutritional supplements and personal care products, including herbs, vitamins, and minerals, as well as natural skin, hair, and body care products under the RBC Life Sciences brand. It markets these products in various categories comprising wellness products, weight loss products, fitness products, and skin care products. This segment markets its products through a network of independent associates, as well as through licensing arrangements with third parties. The Medical Products segment markets a line of approximately 28 wound care products under the MPM Medical brand name. This segment’s products include cleansers, dressings, hydrogels, calcium alginates, moisture barriers, antimicrobials, and a hydrogel wound dressing with Lidocaine, as well as other products, which reduce destruction to skin and tissue caused by radiation, and to reduce pain and itching caused by radiation reactions in the skin and the internal mucosa caused by radiation reactions or reactions to certain cancer medications. Its wound care products are used for the treatment and healing of wounds, such as pressure ulcers, leg ulcers, cuts, burns, and abrasions, as well as to manage pain associated with these wounds in the acute care, long-term care, oncology, and podiatry markets. This segment distributes products to hospitals, nursing homes, clinics, pharmacies, and home health care agencies through medical/surgical supply dealers and pharmaceutical distributors. The company was formerly known as Royal BodyCare, Inc. and changed its name to RBC Life Sciences, Inc. in June 2006. RBC Life Sciences, Inc. was founded in 1988 and is headquartered in Irving, Texas.
Key Statistics
More from Reuters
Expanded Business Description

 COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on RBC Life Sciences Inc.


    More from Reuters
    Reuters offers more in-depth Company Research , Stock Screening , and >Risk Alerts on over 10,000 U.S. Equities.

     REUTERS ABRIDGED FINANCIAL SUMMARY 
    View Financials
    More from Reuters
    Significant Developments - Highlights - Performance - Ratio Comparison


     OFFICERS 
     PayExercised
    Mr. Clinton H. Howard , 81
    Founder and Exec. Chairman
    N/A N/A
    Mr. John W. Price , 66
    Chief Exec. Officer, Pres
    $ 336.00KN/A
    Mr. Steve Brown , 54
    Chief Financial Officer, Principal Accounting Officer, VP of Fin., Sec.
    N/A N/A
    Mr. Kenneth L. Sabot , 64
    Sr. VP of Operations
    N/A N/A
    Mr. Paul R. Miller , 68
    Director and Pres of MPM Medical Inc
    $ 2.00KN/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders
    More from Reuters:
    Full List - Bios - Compensation - Options


    加進我的投資組合 加進我的投資組合    寄給朋友 寄給朋友

    資料提供及版權歸於 AASTOCKSDBPower經濟通內幕人 Insiders.hkInteractive Data Real Time Services凱基証券QuamnetTelekurs (USA) INC
    用戶意見 | 私隱政策 | 服務條款 | 免責條款
    Copyright © 2010 Yahoo! Hong Kong Limited. All rights reserved. 版權所有 不得轉載
    免責聲明:以上資料由雅虎香港有限公司的資料提供夥伴(如AASTOCKS、DBPower、經濟通、內幕人Insiders.hk、Interactive Data Real Time Services、凱基証券、Quamnet 和 Telekurs (USA) INC)提供,僅作參考之用,雅虎香港有限公司及資料提供夥伴對以上資訊的準性和可靠性不能亦不會作任何保證或承擔,並對基於該等資料或有關的錯漏或延誤而作出的任何決定或導致的損失概不負責。
    權益披露包括: 法團大股東之交易, 個人大股東之交易, 董事或最高行政人員之交易,及董事或最高行政人員買賣其上市公司的子公司或付屬公司之交易。
    所有股票報價及認股證報價均延遲最少十五分鐘。